Zacks Small-Cap Research Issue Note On ContraFect With $7 Valuation
Portfolio Pulse from Benzinga Newsdesk
Zacks Small-Cap Research has issued a note on ContraFect, assigning a $7 valuation to the company's stock.
May 23, 2023 | 2:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
ContraFect's stock has been valued at $7 by Zacks Small-Cap Research, potentially impacting its stock price.
Zacks Small-Cap Research, a well-known research firm, has issued a note on ContraFect, assigning a $7 valuation to the company's stock. This valuation could potentially impact the stock price of ContraFect (CFRX) in the short term, as investors may adjust their positions based on this new information.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100